Introduction
============

Dermoscopy is a noninvasive method that allows in vivo evaluation of microstructures of the epidermis, the dermoepidermal junction, and the papillary dermis otherwise not visible to the naked eye. Dry dermoscopy, also called trichoscopy, is ideal because it has a blocking filter against light reflection from the skin surface. Sometimes differentiating scarring alopecia from non-scarring alopecia is difficult and dermoscopy can be helpful at this stage. Characteristic dermoscopic features of AA are yellow dots, black dots, broken hairs, tapering hair (exclamation marks), and short vellus hairs \[[@b1-dp0702a12]--[@b4-dp0702a12]\].

Materials and Methods
=====================

A retrospective analysis of 72 patients suffering from alopecia areata, irrespective of age and sex, who visited the dermatology outpatient department was carried out. Institutional Ethical Committee clearance was obtained. All patients visiting the dermatology outpatient department were screened for AA. All patients with alopecia areata, including those under treatment, were included in the study. The clinical diagnosis of AA was established after a detailed history and clinical examination. Relevant investigations like 10% KOH preparation and biopsy was carried out in select cases. Thyroid profile was performed in all cases. The various patterns of AA were noted as patchy, diffuse, ophiasis, totalis, and universalis. The severity of AA was graded on the basis of the Severity of Alopecia Tool (SALT) score. Dermoscopy was performed using Dermlite II hybrid m (3Gen, San Juan Capistrano, CA) dermatoscope at 10X magnification in polarized mode and photographs were captured with an iPhone 6 (Apple, Cupertino, CA). Dermoscopy image capturing was performed by a single dermoscopist to ensure consistent photographs during the procedure \[[@b5-dp0702a12]\]. Dermoscopic variables included yellow dots (YDs), black dots, broken hair, exclamation mark hair, short vellus hair and any other new findings. White dots were differentiated from yellow dots by three independent dermoscopists. In accordance with available literature and data, yellow dots and black dots were considered the most common variables for severity. Additionally an increased number of yellow dots, broken dots, or broken hairs per field of vision was considered as an increase in severity of AA.

Results
=======

All patients were of the South Asian ethnic group and of Indo-Aryan race from northern India with mainly Fitzpatrick skin type 4 and 5 (dark brown color).

Age and gender
--------------

There were 41 male (56.94%) and 31 female (43.05%) patients. The male to female ratio was 1.3:1, with a mean age of 24.43 years, median 24, and range from 5--50 years. The most common age group for AA in our study was seen in the 21--40 year age group.

History and associated disorders
--------------------------------

Family history of AA was positive in 5 cases (6.94%). Ten patients were positive for thyroid autoantibodies (13.88%). Coexisting autoimmune disease such as vitiligo was seen in one patient (1.38%) and psoriasis in one patient (1.38%).

Type of AA
----------

Patients with progressive AA numbered 56 (77.77%), whereas 16 patients (22.22%) had non-progressive AA. Only scalp involvement was seen in 40 cases (55.55%). In the scalp, common sites involved were occipital (13 patients) and parietal regions (11 patients). Other sites involved were temporal (4 patients); frontal (4 patients); vertex (3 cases); whole scalp (5 cases); only beard involvement in 12 cases (16.66%); only eyebrow involvement in 1 case (1.38%); only eyelash involvement in 1 case (1.38%); ophiasis in 5 cases (6.94%); sisiapho in 3 cases (4.1%); alopecia totalis in 9 cases; and alopecia universalis in 5 cases (6.94%). Patchy alopecia was the most common type (50/72, 69.4%); single patch AA was discovered in 21 cases (29.16%); and multiple patch AA in 29 cases (40.27%) ([Table 1](#t1-dp0702a12){ref-type="table"}).

Yellow dots were seen in 57 cases (79.16%), black dots in 51 cases (70.8%), short vellus hair was seen in 32 cases (44.44%), broken hair was seen in 31 cases (43.05%), and exclamation mark hair in 23 cases (31.9%). The maximum number of yellow dots per field of vision were seen in all cases of alopecia universalis. The occurrence of YDs and BDs were seen together in 39 cases of progressive AA, YDs and BH in 31 cases, YDs, BDs and BH together in 23 cases. YDs and SVH in 19 cases, YDs and EMH in 19 cases ([Figures 1](#f1-dp0702a12){ref-type="fig"}[](#f2-dp0702a12){ref-type="fig"}[](#f3-dp0702a12){ref-type="fig"}[](#f4-dp0702a12){ref-type="fig"}[](#f5-dp0702a12){ref-type="fig"}[](#f6-dp0702a12){ref-type="fig"}--[7](#f7-dp0702a12){ref-type="fig"}).

Treatment
---------

Five patients were given intralesional triamcinolone acetonide. One patient with coexistent stable vitiligo was given bimatprost 0.03% ophthalmic solution, as there was presence of leukotrichia with the patch. An increased number of terminal hairs along with growth of SVH were seen in 5 out of 7 cases on treatment. White peripilar sign ([Figure 8](#f8-dp0702a12){ref-type="fig"}) was also seen in 4 out of 7 cases after treatment, with two to three hair units emerging from each follicle---a sign of hair regrowth.

Discussion
==========

A study done by Inui et al \[[@b2-dp0702a12]\] of 300 patients with AA, in different stages and different subtypes of the disease, identified yellow dots, black dots, broken hairs, coudability hairs, and clustered short vellus hairs (\<10 mm) as the most common features \[[@b6-dp0702a12]\]. Yellow dots and short vellus hairs were the most sensitive markers for the diagnosis, and black dots, tapering hairs, and broken hairs were the most specific markers \[[@b2-dp0702a12]\]. Yellow dots present as round or polycyclic yellow to yellow-pink dots that may be devoid of hairs or contain miniaturized, cadaverized, or dystrophic hairs. Although the yellow dots are sensitive (detected in all of 58 patients with different types of AA \[[@b6-dp0702a12]\]), they correspond on pathology to the dilated infundibular ostia filled with sebum and degenerated follicular keratinocytes \[[@b1-dp0702a12],[@b7-dp0702a12]\]. In our study, yellow dots ([Figures 1](#f1-dp0702a12){ref-type="fig"}, [2](#f2-dp0702a12){ref-type="fig"}) were the most common finding seen in 57 cases (79.16%). In a study conducted by Inui et al \[[@b4-dp0702a12]\], YDs were seen in 63.7% (191/300) of cases in contrast to Ross et al's study, where 94.8% cases with AA had YDs (55/58 cases) \[[@b8-dp0702a12]\]. Mane et al \[[@b3-dp0702a12]\] reported an incidence of 81.8% among 66 patients and Hegde et al \[[@b9-dp0702a12]\] reported the incidence of YDs was 57.3%. Yellow dots per field of vision, as described by Bapu et al, was seen in all cases of AU depicting increased severity of disease \[[@b10-dp0702a12]\].

Black dots (cadaverized hairs) and broken hairs correspond to the fragmented and destroyed hair shafts and represent a sign of disease activity. Black dots are only seen in dark-haired individuals. Inui et al \[[@b2-dp0702a12]\], demonstrated BDs in 44.3% (133/300) cases of AA. Mane et al reported 67.7% (44/66) of patients had BDs \[[@b3-dp0702a12]\] and Hegde et al \[[@b9-dp0702a12]\] in 84% of cases. In our study BDs ([Figures 3](#f3-dp0702a12){ref-type="fig"},[5](#f5-dp0702a12){ref-type="fig"}) were seen in 51 cases (70.8%).

Short vellus hairs (\<10 mm) are a relatively common finding in AA (44.37%) \[[@b10-dp0702a12]\]. They may be white and are most prevalent in the remitting stage of AA. Short vellus hairs may appear as circle hairs and is a predominant feature in some patients. Inui et al \[[@b2-dp0702a12]\] observed SVHs in 72.7% (218/300) of cases. Mane et al \[[@b3-dp0702a12]\] demonstrated SVHs in 40.9% of patients, Hegde et al \[[@b9-dp0702a12]\] demonstrated SVHs in 68% of cases. In our study SVHs and curly hairs (CHs) ([Figures 5](#f5-dp0702a12){ref-type="fig"}, [6](#f6-dp0702a12){ref-type="fig"}) were noted in 32 cases (44.44%).

Broken hairs are not exclusive to AA, as they are seen also in trichotillomania \[[@b1-dp0702a12],[@b3-dp0702a12]\]. Inui et al \[[@b4-dp0702a12]\] demonstrated BHs in 45.7% (137/300) of alopecia cases. Mane et al observed 55.4% patients with BH \[[@b3-dp0702a12]\], and Hegde et al \[[@b9-dp0702a12]\] reported the incidence of BH in 37.33% of cases. In our study BHs ([Figure 3](#f3-dp0702a12){ref-type="fig"}) was seen in 31 cases (43.05%).

Tapering hairs include exclamation mark hairs and coudability hairs and are a marker for disease activity and severity \[[@b4-dp0702a12],[@b11-dp0702a12]\]. In our study THs were noted in 23 cases (31.9%). Inui et al noted THs in 31.7% (95/300) cases of AA \[[@b2-dp0702a12]\], Mane et al \[[@b3-dp0702a12]\] 12.1% (8/66), and Hegde et al \[[@b9-dp0702a12]\] 14 (18.67%) cases of THs ([Figure 3](#f3-dp0702a12){ref-type="fig"}).

One patient with coexistent stable vitiligo was given bimatprost 0.03% ophthalmic solution, as there was presence of leukotrichia with the patch. In one study, after one patient was prescribed bimatoprost 0.03% ophthalmic solution for six weeks, there was partial repigmentation of the depigmented area, but the treatment was stopped due to localized hypertrichosis \[[@b12-dp0702a12]\]. Another study showed partial repigmentation of leukotrichia \[[@b13-dp0702a12]\]. White peripilar sign was also seen in 4 out of 7 cases on treatment with two to three hair units emerging from each follicl---a sign of hair regrowth. Although white peripilar has been described in other disorders to assess severity of disease, we found this to be a sign denoting hair growth.

Conclusion
----------

YDS in increased number per field of vision is the most consistent finding and are seen with severe cases of AA, as they are in progressive AA and alopecia universalis. An increased number of SVH and terminal hairs were seen in patients who were being treated.
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###### 

Patient demographics. \[Copyright: ©2017 Jha et al.\]

  Age group (years)   Clinical Type of Vitiligo                                      
  ------------------- --------------------------- -------- ------ ---- ---- ---- --- ---
  0--20               21--40                      41--60   \>60                      
  22                  41                          9        0      41   31   56   9   7
